Dose-response Relationship of Mustard Flour Footbaths in Healthy Volunteers
1 other identifier
interventional
16
1 country
1
Brief Summary
A study to explore whether different dosages of mustard flour in footbaths cause different effects on warmth development as well as on general well-being and the autonomic nervous system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 17, 2020
CompletedFirst Posted
Study publicly available on registry
March 25, 2020
CompletedStudy Start
First participant enrolled
April 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 25, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 26, 2020
CompletedSeptember 21, 2020
September 1, 2020
4 months
March 17, 2020
September 18, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
2-item warmth perception measure at the feet after the footbath
Self-reported warmth perception at both feet, assessed with the "Herdecke warmth perception questionnaire" immediately after the footbath (t2). Each item is scored 0-4 (0 = cold; 4 = hot), yielding a mean between 0 and 4.
Immediately after the footbath, timepoint 2 (t2)
Secondary Outcomes (23)
2-item warmth perception measure at the feet at time point 1 (t1) and time point 3 (t3)
Immediately before (time point 1, t1) and 10 minutes following the footbath (time point 3, t3).
2-item warmth perception measure at the hands at t1, t2 and t3
Immediately before (time point 1, t1), immediately after (time point 2, t2) and 10 minutes following the footbath (time point 3, t3).
2-item warmth perception measure at the head at t1, t2 and t3
Immediately before (time point 1, t1), immediately after (time point 2, t2) and 10 minutes following the footbath (time point 3, t3)
1-item overall warmth perception measure at t1, t2 and t3
Immediately before (time point 1, t1), immediately after (time point 2, t2) and 10 minutes following the footbath (time point 3, t3)
Warmth perception and skin stimulus at the feet during the footbath
Up to 20 minutes
- +18 more secondary outcomes
Study Arms (4)
3-g footbath
EXPERIMENTALFootbath with 3g mustard flour per liter of water
6-g footbath
EXPERIMENTALFootbath with 6g mustard flour per liter of water
12-g footbath
EXPERIMENTALFootbath with 12g mustard flour per liter of water
Warm water footbath
PLACEBO COMPARATORFootbath with warm water only
Interventions
A ten-minute pre-intervention rest period followed by a 20-minute footbath with 12 l of warm water (40 °C) and 36 g mustard flour (3 g per l), followed by a ten-minute post-intervention rest period.
A ten-minute pre-intervention rest period followed by a 20-minute footbath with 12 l of warm water (40 °C) and 72 g mustard flour (6 g per l), followed by a ten-minute post-intervention rest period.
A ten-minute pre-intervention rest period followed by a 20-minute footbath with 12 l of warm water (40 °C) and 144 g mustard flour (12 g per l), followed by a ten-minute post-intervention rest period.
A ten-minute pre-intervention rest period followed by a 20-minute footbath with 12 l of warm water (40 °C), followed by a ten-minute post-intervention rest period.
Eligibility Criteria
You may qualify if:
- Written informed consent;
- Age between 18 and 55 years
You may not qualify if:
- Chronic skin lesions at the lower legs or feet
- Varicose veins grade 3 and grade 4 (Marshall stage classification)
- Chronic venous insufficiency
- Known intolerance or hypersensitivity to mustard preparations
- Cardiac arrhythmia
- Cardiac pacemaker
- Asthma bronchiale
- Consumption of HRV-modulating medication (especially tricyclic antidepressants, beta blockers)
- Pregnancy
- Insufficient knowledge of the german language
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Arcim Institute
Filderstadt, Baden-Wurttemberg, 70794, Germany
Study Officials
- PRINCIPAL INVESTIGATOR
Jan Vagedes, MD
ARCIM Institute Academic Research in Complementary and Integrative Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 17, 2020
First Posted
March 25, 2020
Study Start
April 20, 2020
Primary Completion
August 25, 2020
Study Completion
August 26, 2020
Last Updated
September 21, 2020
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- The data will be made available upon publication for a duration of three months.
- Access Criteria
- The data will be made available to researchers who provide a methodologically sound proposal for use in achieving the goals of the approved proposal.
Deidentified individual participant data will be made available, in addition to study protocol and informed consent form.